GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Multi-scale analysis of Bacillus Calmette-Guérin (BCG) resistant tumor micro-environment in non-muscle invasive bladder cancer to identify novel therapeutic axis

$684,877
Won-Min Song · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC

$684,630
Nabeel Bardeesy · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA

Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity

$684,604
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity

$684,604
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

TET2-mediated epitranscriptomic regulation in leukemia microenvironment

$684,584
Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy

$684,576
Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA

Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis

$684,514
Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2022 · CA

Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer

$684,367
Yanhong Liu · Baylor College Of Medicine · R01 · FY2024 · CA

TET2-mediated epitranscriptomic regulation in leukemia microenvironment

$684,230
Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation

$683,986
Cheryl A London · Tufts University Boston · U01 · FY2024 · CA

Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer

$683,864
Xiling Shen · Duke University · U01 · FY2019 · CA

Mechanisms of tumorigenesis in Brg1 mutant lung cancer

$683,713
Carla F. Kim · Boston Children'S Hospital · R01 · FY2018 · CA

The Epigenetic Enzyme CARM1 as a Negative Regulator of Dendritic cells and CD8 T cells in Melanoma

$683,670
Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2025 · CA

Project 1 - Evolutionary and ecological dynamics of tumor-host interactions

$683,635
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2017 · CA

Mapping Immune Contexture and Crosstalk with Tumor Cells At GBM Margin

$683,211
Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS

Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture

$682,915
Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA

Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients

$682,907
Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2024 · CA

(PQC4) Habitats in Prostate Cancer

$682,812
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA

Image-guided cancer therapy using heat activatable CAR T cells

$682,800
Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2022 · EB

Artificial Intelligence Boosted Evolution and Detection of Genetically Encoded Reporters for In Vivo Imaging

$682,727
Christian T Farrar · Massachusetts General Hospital · R01 · FY2022 · EB

Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122

$682,689
David A. Hafler · Yale University · R01 · FY2025 · CA

Metabolic mechanisms of glioma progression

$682,596
Samuel Kent McBrayer · Ut Southwestern Medical Center · R01 · FY2025 · CA

Therapeutic targeting MDSC-mediated immune suppression in cancer

$682,585
Yulia Nefedova · Wistar Institute · R01 · FY2023 · CA

Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy

$682,539
Daniel B Stetson · University Of Washington · R01 · FY2023 · CA

Precision Therapy to Target Pancreatic Ductal Adenocarcinoma

$682,524
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA